Aims: To determine the relative diagnostic sensitivity of non-isotopic in situ hybridisation (NISH) 
nosis of human papillomavirus (HPV) on matched smears and biopsy specimens; to compare the NISH signal type in the two samples; and to correlate the NISH data with the morphological diagnosis. Methods: HPV samples were assayed individually by NISH with digoxigenin labelled probes (HPV6, 11, 16, 18 , and 33) on routinely collected paraffin wax embedded cervical biopsy specimens and for high risk HPVs with a cocktail of similarly labelled probes (HPV16, 18, 33) on matched smears. These were taken at the same colposcopic examination from 32 patients investigated for an abnormal cervical Papinacolau (PAP) stained smear.
Results: An HPV signal was present in 18 (56%) biopsy specimens and in 14 (44%) smears. There was higher concordance of sets of data in the presence of cytopathic wart virus changes. The superiority of biopsy over smear in detecting HPV was mainly the result of examining the entire cervical biopsy specimen rather than cells scraped from the cervical surface. The 
DETECTION OF NISH SIGNAL ON SMEARS AND SECTIONS
For comparability, the same three-step detection system'0 was used for sections and smears to ensure the same degree of sensitivity on smears and sections. After hybridisation, both samples were washed twice in 4 x SSC and soaked in blocking agent (TBT) containing 50 mM TRIS-HCl (pH7-2), 100 mM NaCl, 1 mM MgCl2, 3% (w/v) bovine serum albumin, 0-05% (v/v) Triton x 100. Samples were incubated in antidigoxin monoclonal antibody (Sigma UK) diluted 1 in 10 000 in TBT for 30 minutes, followed by biotinylated rabbit-anti mouse F(ab')% fragment (Dako UK) diluted 1 in contaminant introduced by smear taking or in the laboratory performing the analysis. HPV genomes can only be unequivocally attributed to epithelial cells by in situ hybridisation. In the present study NISH was performed on routine cervical smears and the results compared with in situ detection of HPV on the matched biopsy specimen. This approach offers the advantage of comparing a highly sensitive technique (2-5 to 12 copies of HPV/cell'0), performed on the individual cells with the tissue from which they were collected. Apart from different fixation and pretreatment of the smears and biopsy specimen hybridisation was carried out under the same stringency conditions and HPV was visualised by the same detection system.
A high rate of concordance was observed when wart virus infection changes were associated with cervical dysplasia, HPV being detected in 57% of the biopsy specimens and 53% of the smears. The only significant difference in the results on the two sample types was in the case of CIN III, without wart virus infection, where 63% of biopsy specimens contained a signal compared with 33% on smears. These data underline the different rate of HPV detection in dysplastic smears with and without wart virus infection associated changes and concur with data reported by isotopic in situ hybridisation. 22 
